The emergence of AI and biosensors offers a chance to address inefficiencies in drug development.

Diversity in clinical trials matters for drug safety and efficacy—and for future medical advancements. Clinical trial ...

While there are shared principles across development programs, Barr noted that the nuances within immunology, ophthalmology, or chronic care studies can determine whether a trial succeeds or fails.

Raja Shankar, VP of machine learning at IQVIA, discusses which AI capabilities sponsors are most likely to adopt first to ...

Note: This is the third article of a three-part series. Real-world evidence (RWE) plays a crucial role in supporting the benefits of one drug over another in debates that play out on the boards and ...

The integration of real-world data (RWD) into protocol feasibility and site selection has emerged as a clinical trial game-changer in recent years. Traditionally relying heavily on data from carefully ...

In understanding what makes the patient voice so essential to successful drug development, let’s take a critical eye to what ...

Even when promising clinical trials exist, and the FDA allows expanded access, rare disease patients like my granddaughter ...